
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A small molecule inhibitor of the UBE2F-CRL5 axis induces apoptosis and radiosensitization in lung cancer
Tiantian Xu, Qisheng Ma, Yanan Li, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 31
Tiantian Xu, Qisheng Ma, Yanan Li, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
Molecular mechanisms of tumor resistance to radiotherapy
Yu Wu, Yingqiu Song, Runze Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 182
Yu Wu, Yingqiu Song, Runze Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 182
Protein neddylation and its role in health and diseases
Shizhen Zhang, Qing Yu, Zhijian Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 35
Shizhen Zhang, Qing Yu, Zhijian Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 35
Ang-1 and VEGF: central regulators of angiogenesis
Yuanqin Zhao, Bo Yu, Yanxia Wang, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 9
Yuanqin Zhao, Bo Yu, Yanxia Wang, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 9
RHEB neddylation by the UBE2F-SAG axis enhances mTORC1 activity and aggravates liver tumorigenesis
Zhang Feng-wu, Xiufang Xiong, Zhijian Li, et al.
The EMBO Journal (2025) Vol. 44, Iss. 4, pp. 1185-1219
Closed Access | Times Cited: 1
Zhang Feng-wu, Xiufang Xiong, Zhijian Li, et al.
The EMBO Journal (2025) Vol. 44, Iss. 4, pp. 1185-1219
Closed Access | Times Cited: 1
NEDD8-conjugating enzyme E2s: critical targets for cancer therapy
Lisha Zhou, Xiongzhi Lin, Jin Zhu, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 18
Lisha Zhou, Xiongzhi Lin, Jin Zhu, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 18
Development and experimental validation of a machine learning-based disulfidptosis-related ferroptosis score for hepatocellular carcinoma
Cong Zhang, Tiantian Xu, Kun Ji, et al.
APOPTOSIS (2023) Vol. 29, Iss. 1-2, pp. 103-120
Closed Access | Times Cited: 16
Cong Zhang, Tiantian Xu, Kun Ji, et al.
APOPTOSIS (2023) Vol. 29, Iss. 1-2, pp. 103-120
Closed Access | Times Cited: 16
Neddylation and MASLD : From Pathophysiology to Therapy
Wenjun Lin, Wenfang Zheng, Ning Dai, et al.
Liver International (2025) Vol. 45, Iss. 5
Closed Access
Wenjun Lin, Wenfang Zheng, Ning Dai, et al.
Liver International (2025) Vol. 45, Iss. 5
Closed Access
Targeting cullin neddylation for cancer and fibrotic diseases
Zhangxu He, Wei-guang Yang, Dan Zengyangzong, et al.
Theranostics (2023) Vol. 13, Iss. 14, pp. 5017-5056
Open Access | Times Cited: 12
Zhangxu He, Wei-guang Yang, Dan Zengyangzong, et al.
Theranostics (2023) Vol. 13, Iss. 14, pp. 5017-5056
Open Access | Times Cited: 12
Novel Siglec-15-Sia axis inhibitor leads to colorectal cancer cell death by targeting miR-6715b-3p and oncogenes
Mohammed Saqif Ahmad, Maria Braoudaki, Hershna Patel, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Mohammed Saqif Ahmad, Maria Braoudaki, Hershna Patel, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Association of thrombocytopenia with immune checkpoint inhibitors: a large-scale pharmacovigilance analysis based on the data from FDA adverse event reporting system database
G. Liu, Shuxian Zhang, Zhuang Mo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
G. Liu, Shuxian Zhang, Zhuang Mo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Intracellular metal ion-based chemistry for programmed cell death
Y You, Zhongying Guo, Tyler Wolter, et al.
Chemical Society Reviews (2025)
Closed Access
Y You, Zhongying Guo, Tyler Wolter, et al.
Chemical Society Reviews (2025)
Closed Access
The novel piperine derivative MHJ-LN inhibits breast cancer by inducing apoptosis via p53 activation
Hongyu Ren, Qi Gao, Mengmeng Wang, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Hongyu Ren, Qi Gao, Mengmeng Wang, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
E2 conjugating enzymes: A silent but crucial player in Ubiquitin Biology
Somya Parashar, Aastha Kaushik, Rashmi K. Ambasta, et al.
Ageing Research Reviews (2025), pp. 102740-102740
Closed Access
Somya Parashar, Aastha Kaushik, Rashmi K. Ambasta, et al.
Ageing Research Reviews (2025), pp. 102740-102740
Closed Access
Deubiquitinating enzyme USP28 inhibitor AZ1 alone and in combination with cisplatin for the treatment of non-small cell lung cancer
Yiqiong Song, Longhao Wang, Yuanyuan Zheng, et al.
APOPTOSIS (2024) Vol. 29, Iss. 9-10, pp. 1793-1809
Open Access | Times Cited: 3
Yiqiong Song, Longhao Wang, Yuanyuan Zheng, et al.
APOPTOSIS (2024) Vol. 29, Iss. 9-10, pp. 1793-1809
Open Access | Times Cited: 3
Neddylation Regulation of Immune Responses
Hongmei Mao, Xin Lin, Yi Sun
Research (2023) Vol. 6
Open Access | Times Cited: 8
Hongmei Mao, Xin Lin, Yi Sun
Research (2023) Vol. 6
Open Access | Times Cited: 8
Advances in the potential roles of Cullin-RING ligases in regulating autoimmune diseases
Xiaoying Zhang, Yue Liu, Tong Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Xiaoying Zhang, Yue Liu, Tong Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
The Double-Edged Effects of MLN4924: Rethinking Anti-Cancer Drugs Targeting the Neddylation Pathway
Haoming Tang, Xin Pang, Shun Li, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 738-738
Open Access | Times Cited: 2
Haoming Tang, Xin Pang, Shun Li, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 738-738
Open Access | Times Cited: 2
Self-crosslinking hyaluronic acid-based hydrogel with promoting vascularization and ROS scavenging for wound healing
Wenning Zhang, Han Wang, Jie Pang, et al.
International Journal of Biological Macromolecules (2024) Vol. 278, pp. 134570-134570
Closed Access | Times Cited: 2
Wenning Zhang, Han Wang, Jie Pang, et al.
International Journal of Biological Macromolecules (2024) Vol. 278, pp. 134570-134570
Closed Access | Times Cited: 2
Discovery of neddylation E2s inhibitors with therapeutic activity
MAA Mamun, Ying Liu, Yin-Ping Geng, et al.
Oncogenesis (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 5
MAA Mamun, Ying Liu, Yin-Ping Geng, et al.
Oncogenesis (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 5
RNA methylation, homologous recombination repair and therapeutic resistance
Yu Bai, Hanlin Zhao, Haijun Liu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115409-115409
Open Access | Times Cited: 4
Yu Bai, Hanlin Zhao, Haijun Liu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115409-115409
Open Access | Times Cited: 4
Proapoptotic effect of WS-299 induced by NOXA accumulation and NRF2-counterbalanced oxidative stress damage through targeting RBX1-UBE2M interaction in gastric cancers
Ting Ma, Qianqian Song, Bing Cheng, et al.
Bioorganic Chemistry (2024) Vol. 144, pp. 107142-107142
Closed Access | Times Cited: 1
Ting Ma, Qianqian Song, Bing Cheng, et al.
Bioorganic Chemistry (2024) Vol. 144, pp. 107142-107142
Closed Access | Times Cited: 1
ncRNAs Orchestrate Chemosensitivity Induction by Neddylation Blockades
Andrea Pérez-González, Ivonne Ramírez‐Díaz, Josué Guzmán-Linares, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 825-825
Open Access | Times Cited: 1
Andrea Pérez-González, Ivonne Ramírez‐Díaz, Josué Guzmán-Linares, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 825-825
Open Access | Times Cited: 1
Discovery of small molecule inhibitors of neddylation catalyzing enzymes for anticancer therapy
Xiangshuo Qin, Xin Han, Yi Sun
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117356-117356
Open Access | Times Cited: 1
Xiangshuo Qin, Xin Han, Yi Sun
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117356-117356
Open Access | Times Cited: 1
Inhibiting Neddylation: A New Strategy for Tumor Therapy
Jian‐Jun Sun, Cui Liu, Changhui Lang, et al.
Journal of Pharmaceutical Analysis (2024), pp. 101140-101140
Open Access | Times Cited: 1
Jian‐Jun Sun, Cui Liu, Changhui Lang, et al.
Journal of Pharmaceutical Analysis (2024), pp. 101140-101140
Open Access | Times Cited: 1
E3 ubiquitin ligases in lung cancer: Emerging insights and therapeutic opportunities
Bhaskar Basu, Satadeepa Kal, Subhajit Karmakar, et al.
Life Sciences (2023) Vol. 336, pp. 122333-122333
Closed Access | Times Cited: 2
Bhaskar Basu, Satadeepa Kal, Subhajit Karmakar, et al.
Life Sciences (2023) Vol. 336, pp. 122333-122333
Closed Access | Times Cited: 2